Manufacturer record
Oxalis Labs: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Oxalis Labs (Himachal Pradesh) were declared Not of Standard Quality between June 2022 and June 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Oxalis Labs in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Flutrol 250 (Salmeterol and Fluticasone Propionate Inhalation I.P.) | NSB2206AMfg 2022-04 · Exp 2025-03 | Assay of Salmeterol Xinafoate and Fluticasone PropionateAssay | CDL KolkataCDSCO lab | Jun 2023 |
| Salmeterol 25 mcg and Fluticasone Propionate 250 mcg Inhalation IP | NSB2201CMfg 2022-01 · Exp 2024-12 | AssayAssay | CDL KolkataCDSCO lab | Jun 2022 |
| Salmeterol 25 mcg and Fluticasone Propionate 250 mcg Inhalation IP | NSB2201BMfg 2022-01 · Exp 2024-12 | AssayAssay | CDL KolkataCDSCO lab | Jun 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.